In prostate cancer cell lines, transgenic mouse models and human prostate tumor cohorts, scientists confirmed that YAP1 RNA and YAP1 protein expression were silenced in neuroendocrine prostate cancer.
[Journal of Pathology]
6445218
{6445218:ARVTBK39}
apa
50
1
166105
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-c5b2edec7d2111aa1e18ca450b277615%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ARVTBK39%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Asrani%20et%20al.%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAsrani%2C%20K.%2C%20Torres%2C%20A.%20F.%20C.%2C%20Woo%2C%20J.%2C%20Vidotto%2C%20T.%2C%20Tsai%2C%20H.%20K.%2C%20Luo%2C%20J.%2C%20Corey%2C%20E.%2C%20Hanratty%2C%20B.%2C%20Coleman%2C%20I.%2C%20Yegnasubramanian%2C%20S.%2C%20Marzo%2C%20A.%20M.%20D.%2C%20Nelson%2C%20P.%20S.%2C%20Haffner%2C%20M.%20C.%2C%20%26amp%3B%20Lotan%2C%20T.%20L.%20%28n.d.%29.%20Reciprocal%20YAP1%20loss%20and%20INSM1%20expression%20in%20neuroendocrine%20prostate%20cancer.%20%3Ci%3EThe%20Journal%20of%20Pathology%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fpath.5781%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fpath.5781%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DARVTBK39%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Reciprocal%20YAP1%20loss%20and%20INSM1%20expression%20in%20neuroendocrine%20prostate%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaushal%22%2C%22lastName%22%3A%22Asrani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alba%20F.%20C.%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juhyung%22%2C%22lastName%22%3A%22Woo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thiago%22%2C%22lastName%22%3A%22Vidotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harrison%20K.%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Corey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Hanratty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilsa%22%2C%22lastName%22%3A%22Coleman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinivasan%22%2C%22lastName%22%3A%22Yegnasubramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelo%20M.%20De%22%2C%22lastName%22%3A%22Marzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20S.%22%2C%22lastName%22%3A%22Nelson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20C.%22%2C%22lastName%22%3A%22Haffner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamara%20L.%22%2C%22lastName%22%3A%22Lotan%22%7D%5D%2C%22abstractNote%22%3A%22Neuroendocrine%20prostate%20cancer%20%28NEPC%29%20is%20a%20rare%20but%20aggressive%20histologic%20variant%20of%20prostate%20cancer%20that%20responds%20poorly%20to%20androgen%20deprivation%20therapy.%20Hybrid%20NEPC-adenocarcinoma%20%28AdCa%29%20tumors%20are%20common%2C%20often%20eluding%20accurate%20pathologic%20diagnosis%20and%20requiring%20ancillary%20markers%20for%20classification.%20We%20recently%20performed%20an%20outlier-based%20meta-analysis%20across%20a%20number%20of%20independent%20gene%20expression%20microarray%20datasets%20to%20identify%20novel%20markers%20that%20differentiate%20NEPC%20from%20AdCa%2C%20including%20up-regulation%20of%20Insulinoma-associated%20protein%201%20%28INSM1%29%20and%20loss%20of%20Yes-associated%20protein%201%20%28YAP1%29.%20Here%2C%20using%20diverse%20cancer%20gene%20expression%20datasets%2C%20we%20show%20that%20Hippo%20pathway-related%20genes%2C%20including%20YAP1%2C%20are%20among%20the%20top%20down-regulated%20gene%20sets%20with%20expression%20of%20the%20neuroendocrine%20transcription%20factors%2C%20including%20INSM1.%20In%20prostate%20cancer%20cell%20lines%2C%20transgenic%20mouse%20models%20and%20human%20prostate%20tumor%20cohorts%2C%20we%20confirm%20that%20YAP1%20RNA%20and%20YAP1%20protein%20expression%20are%20silenced%20in%20NEPC%20and%20demonstrate%20that%20the%20inverse%20correlation%20of%20INSM1%20and%20YAP1%20expression%20helps%20to%20distinguish%20AdCa%20from%20NEPC.%20Mechanistically%2C%20we%20find%20that%20YAP1%20loss%20in%20NEPC%20may%20help%20to%20maintain%20INSM1%20expression%20in%20prostate%20cancer%20cell%20lines%20and%20we%20further%20demonstrate%20that%20YAP1%20silencing%20likely%20occurs%20epigenetically%2C%20via%20CpG%20hypermethylation%20near%20its%20transcriptional%20start%20site.%20Taken%20together%2C%20these%20data%20nominate%20two%20additional%20markers%20to%20distinguish%20NEPC%20from%20AdCa%20and%20add%20to%20data%20from%20other%20tumor%20types%20suggesting%20that%20Hippo%20signaling%20is%20tightly%20reciprocally%20regulated%20with%20neuroendocrine%20transcription%20factor%20expression.%20This%20article%20is%20protected%20by%20copyright.%20All%20rights%20reserved.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Fpath.5781%22%2C%22ISSN%22%3A%221096-9896%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fpath.5781%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-25T22%3A41%3A37Z%22%7D%7D%5D%7D
Asrani, K., Torres, A. F. C., Woo, J., Vidotto, T., Tsai, H. K., Luo, J., Corey, E., Hanratty, B., Coleman, I., Yegnasubramanian, S., Marzo, A. M. D., Nelson, P. S., Haffner, M. C., & Lotan, T. L. (n.d.). Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer. The Journal of Pathology, n/a(n/a). https://doi.org/10.1002/path.5781 Cite
